This week the U.S. Food and Drug Administration updated its previous warnings on a group of strong antibiotics known as fluoroquinolones. The FDA will now require additional information be printed on the boxes, labels and patient medication guides to include warnings of potentially serious side effects on muscles, joints and nerves. It is also recommended that this class of antibiotics only be used for severe bacterial infections.

Continue Reading: FDA Increases Warnings for Levaquin and Additional Antibiotics